ÀÌ»ó¿­ ¸íÀÇ

¸ÂÃãÇü ´ë»çÁúȯ °ü¸®ÀÇ Çõ½ÅÀ» À̲ô´Â ¸®´õ

ÀÌ»ó¿­ ¸íÀÇ

  • ¼Ò ¼Ó
    °æÈñ´ëÇб³º´¿ø
  • Áø·á°ú
    ³»ºÐºñ³»°ú
  • Àü¹®ºÐ¾ß
    ´ç´¢º´, °©»ó¼±Áúȯ, ³­ÁøÅ¬¸®´Ð, ºñ¸¸

´ç´¢º´, ºñ¸¸, ´ë»çÁõÈıº Ä¡·áÀÇ Àü¹®°¡·Î ¼Õ²ÅÈ÷´Â ÀÌ»ó¿­ ±³¼ö´Â ȯÀÚ ¸ÂÃãÇü Ä¡·á °èȹ ¼ö¸³¿¡ Ź¿ùÇÑ ¼º°ú¸¦ º¸À̰í ÀÖ´Ù. ÃֽŠġ·á ±â¹ý°ú ¾à¹°À» Ȱ¿ëÇÏ¿© È¿°úÀûÀÎ ´ë»ç Áúȯ °ü¸®¸¦ µ½°í ÀÖÀ¸¸ç, Áö¼ÓÀûÀÎ ¿¬±¸¸¦ ÅëÇØ »õ·Î¿î Ä¡·á¹ý °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ´Ù. ´ÙÇÐÁ¦Àû Á¢±ÙÀ» ÅëÇØ º¹ÇÕÀûÀÎ ´ë»ç Áúȯ¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ °ü¸® ½Ã½ºÅÛÀ» ±¸ÃàÇÏ¿© ȯÀÚµéÀÇ »îÀÇ Áú Çâ»ó¿¡ ±â¿©Çϰí ÀÖ´Ù.

¸íÀÇÇÁ·ÎÇÊ ¸íÀÇ ÇÁ·ÎÇÊ

ÇзÂ

Educational Background
  • °æÈñ´ë ÀÇ´ë Çлç
  • °æÈñ´ë ÀÇ´ë ¼®»ç
  • °æÈñ´ë ÀÇ´ë ¹Ú»ç

ÁÖ¿ä°æ·Â

Work Experience
  • úÞ) °æÈñ´ëÇб³º´¿ø ³»ºÐºñ³»°ú ±³¼ö

¼ö»ó³»¿ª

Awards List
  • °æÈñÀÇÇлó ´ë»ó
  • ´ëÇѳ»°úÇÐȸ Çмú»ó
  • ´ëÇѳ»ºÐºñÇÐȸ EnM ¿¬±¸»ó ¼ö»ó

ÇÐȸȰµ¿

Academic activities
  • ´ëÇÑ´ç´¢º´ÇÐȸ ÇмúÀ§¿øÈ¸ / Áø·áÁöħÀ§¿øÈ¸ / ¿¬±¸À§¿øÈ¸ À§¿ø
  • ´ëÇѳ»ºÐºñÇÐȸ ÇмúÀ§¿øÈ¸ / ±âȹÀ§¿øÈ¸ / ¿¬±¸À§¿øÈ¸ / ¼ö·ÃÀ§¿øÈ¸ À§¿ø
  • ´ëÇѺñ¸¸ÇÐȸ IT À¶ÇÕ ´ë»çÁõÈıº Ä¡·áÀ§¿øÈ¸ ÀÌ»ç
  • Çѱ¹¿ªÇÐȸ ÆíÁýÀ§¿øÈ¸ À§¿ø (SCIE ÇмúÁö Editorial Board)
  • ´ëÇѵðÁöÅÐÇコÇÐȸ ±âȹÀ§¿øÀå / ºòµ¥ÀÌÅÍ ÀÌ»ç
µö¸Þµð½¼
´ëÇ¥¼­Àû

µö¸Þµð½¼

  • ÀúÀÚ(±Û)¿¡¸¯ ÅäÇ® (¹ø¿ª ÀÌ»ó¿­)
  • ÃâÆÇ»ç¼Ò¿ìÁÖ
  • ¹ßÇàÀÏ2020³â 07¿ù 10ÀÏ
Àú¼­ ¾ÆÀÌÄÜ

ÁýÇÊÀú¼­

ÃÑ 5°Ç
Á¦ ¸ñ ´ç´¢º´ÇÐ
ÃâÆÇ»ç ¹ßÇàÀÏ 2018³â 03¿ù
Á¦ ¸ñ ÁúȯÀÚ¿ø ÀÓ»óÁ¤º¸¼öÁý Ç¥ÁØÈ­¸¦ À§ÇÑ °¡À̵å¶óÀÎ
ÃâÆÇ»ç ¹ßÇàÀÏ 2017³â 12¿ù
Á¦ ¸ñ ´ç´¢º´ Ä¡·á Çõ¸í
ÃâÆÇ»ç ¹ßÇàÀÏ 2015³â 09¿ù
Á¦ ¸ñ Çѱ¹ÀÎÀ» À§ÇÑ ´ç´¢º´ ÀÓ»ó Áø·áÁöħ
ÃâÆÇ»ç ¹ßÇàÀÏ 2015³â 03¿ù
¿¬±¸ ¾ÆÀÌÄÜ

ÁÖ¿ä³í¹®

ÃÑ 7°Ç
Á¦ ¸ñ Postprandial Glucose, Insulin, and Glucagon-Like Peptide-1 Responses in Healthy Adults after Consumption of Chocolate-Products
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö
Á¦ ¸ñ Association Between Glycemic Status and the Risk of Parkinson Disease: A Nationwide Population-Based Study
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö
Á¦ ¸ñ Chronic kidney disease and undiagnosed atrial fibrillation in individuals with diabetes
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö
Á¦ ¸ñ Clinical Characteristics and Prevalence of Comorbidities according to Metformin Use in Korean Patients with Type 2 Diabetes
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö
Á¦ ¸ñ A novel non-PPARgamma insulin sensitizer: MLR-1023 clinical proof-of-concept in type 2 diabetes mellitus
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö
Á¦ ¸ñ Optimal fasting plasma glucose and haemoglobin A1c levels for screening of prediabetes and diabetes according to 2-hour plasma glucose in a high-risk population: The Korean Diabetes Prevention Study
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö
Á¦ ¸ñ Orientin reduces the inhibitory effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on adipogenic differentiation and insulin signaling pathway in murine 3T3-L1 adipocytes
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö

¸íÀÇqna ¸íÀÇ ¼Ò¼Óº´¿ø

°æÈñ´ëÇб³º´¿ø

»ó±ÞÁ¾ÇÕº´¿ø
ÀüÈ­ ¾ÆÀÌÄÜ ´ëÇ¥¹øÈ£
02-958-8114
À¥»çÀÌÆ® ¾ÆÀÌÄÜȨÆäÀÌÁö

ÁÖ¿ä½Ã¼³

ÀÀ±Þ½Ç ÀÀ±Þ½Ç
Ŭ¸®´Ð Ŭ¸®´Ð
Á¾ÇÕ°ËÁø¼¾ÅÍ Á¾ÇÕ°ËÁø¼¾ÅÍ
¾Ï¼¾ÅÍ ¾Ï¼¾ÅÍ
ÁÖÂ÷½Ã¼³ ÁÖÂ÷½Ã¼³

°æÈñ´ëÇб³º´¿øÀº ȯÀÚ Áß½ÉÀÇ ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇϸç, ±¹³» ÀÇ·á°è¸¦ ¼±µµÇÏ´Â »ó±ÞÁ¾ÇÕº´¿øÀÔ´Ï´Ù. ÃֽŠÀÇ·á ±â¼ú°ú Àåºñ¸¦ Ȱ¿ëÇÏ¿© ȯÀڵ鿡°Ô ÃÖ»óÀÇ Ä¡·á¸¦ Á¦°øÇÕ´Ï´Ù. ƯÈ÷ ÁßÁõÁúȯ Ä¡·á ¹× ¿¬±¸¿¡ °­Á¡À» º¸À̸ç, ´ÙÇÐÁ¦ ÇùÁø ½Ã½ºÅÛÀ» ÅëÇØ ȯÀÚÀÇ °Ç°­À» ÃÖ¿ì¼±À¸·Î »ý°¢ÇÕ´Ï´Ù. °æÈñ´ëÇб³º´¿øÀº ȯÀÚµéÀÇ ½Å·Ú¿Í ¸¸Á·µµ¸¦ ³ôÀÌ´Â µ¥ ÁÖ·ÂÇϸç, Áö¼ÓÀûÀ¸·Î ÀÇ·á ǰÁú Çâ»ó°ú ¿¬±¸ °³¹ß¿¡ Èû¾²°í ÀÖ½À´Ï´Ù.

°æÈñ´ëÇб³º´¿ø À̹ÌÁö

¼­¿ïƯº°½Ã µ¿´ë¹®±¸ °æÈñ´ë·Î 23 °æÈñ´ëÇб³º´¿ø

Ȩ
³»°¡ ¾Ë°íÀÖ´Â ¸íÀǸ¦ ÃßÃµÇØÁÖ¼¼¿ä